NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. uri icon

Overview

abstract

  • The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

authors

  • Benson, Al B
  • D'Angelica, Michael
  • Abbott, Daniel E
  • Abrams, Thomas A
  • Alberts, Steven R
  • Saenz, Daniel Anaya
  • Are, Chandrakanth
  • Brown, Daniel B
  • Chang, Daniel T
  • Covey, Anne M.
  • Hawkins, William
  • Iyer, Renuka
  • Jacob, Rojymon
  • Karachristos, Andrea
  • Kelley, R Kate
  • Kim, Robin
  • Palta, Manisha
  • Park, James O
  • Sahai, Vaibhav
  • Schefter, Tracey
  • Schmidt, Carl
  • Sicklick, Jason K
  • Singh, Gagandeep
  • Sohal, Davendra
  • Stein, Stacey
  • Tian, G Gary
  • Vauthey, Jean-Nicolas
  • Venook, Alan P
  • Zhu, Andrew X
  • Hoffmann, Karin G
  • Darlow, Susan

publication date

  • May 1, 2017

Research

keywords

  • Carcinoma, Hepatocellular
  • Liver Neoplasms

Identity

PubMed Central ID

  • PMC5557008

Scopus Document Identifier

  • 85019124015

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2017.0059

PubMed ID

  • 28476736

Additional Document Info

volume

  • 15

issue

  • 5